Study 3: Heffernan 2000, oral administration Citation: Heffernan M., Jiang W.J., Thorburn A.W., Ng F.M
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial Summary: This Phase 1b trial assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of co-administering once-weekly subcutaneous cagrilintide (at various doses) with semaglutide 2.4 mg in participants for weight management
as he put it, he felt less like a participant than an observerand a very effective one. Though Phillips sees neuroenhancers as essentially steroids for the brain, they havent yet been banned from poker competitions
It is absorbed in the stomach and small intestine with the help of a protein called intrinsic factor
Experiences vary
A few more data points are worth keeping in view because they round out the safety story
